Juno Therapeutics Investors
Juno Therapeutics is a prominent venture capital fund based in Seattle, Washington, founded in 2013 The firm specializes in advancing innovative therapies in the field of immuno-oncology With a significant investment scale of $264,600,000, Juno Therapeutics is dedicated to developing groundbreaking treatments for cancer The organization focuses on harnessing the power of the immune system to provide effective solutions for patients Juno Therapeutics is committed to fostering scientific advancements and improving patient outcomes through strategic investments
Founded Date:
2013
Last Funding Type:
Series B
Headquarters:
USA
Investors Number:
4
Employee Number:
251-500
Industry:
FemTech
Estimated Revenue:
$100M to $500M
Last Funding Date:
2014-08-05
Number Of Exists:
2
Funding Status:
M&A
Investor Type:
Venture Capital Funds
Total Funding:
310000000